Plain-English translation of NCT06529562 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to treating newly diagnosed nasopharyngeal cancer that combines surgery with reduced-dose radiation and chemotherapy. The goal is to shrink tumors and prevent cancer from returning while causing fewer uncomfortable side effects—like severe dry mouth and difficulty swallowing—than standard treatment causes. Researchers believe this approach may work just as well while being gentler on your body.
Standard radiation therapy for nasopharyngeal cancer, while effective, often causes serious side effects that affect quality of life during and after treatment. This trial exists to see if using surgery first to remove the main tumor, then using lower doses of radiation and chemotherapy, can achieve the same cancer control with fewer of these painful or disabling side effects.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo endoscopic (camera-guided) surgery to remove the tumor from your nasopharynx and nearby lymph nodes in your neck. After surgery heals, you will receive a course of reduced-dose radiation therapy combined with chemotherapy drugs (cisplatin-based regimens). You will be randomly assigned to receive either lower radiation targeting (to specific tumor areas) or lower radiation doses (to a broader area). Throughout treatment and afterward, you will have regular visits to monitor your recovery, side effects, and how well the cancer is controlled.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China